Buy or sell Clinc stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
Clinc Stock
Clinc is a conversational AI platform that enables enterprises to build "human-in-the-room" level, next-gen, virtual assistants.
About Clinc Stock
Clinc is a conversational AI platform that enables enterprises to build "human-in-the-room" level, next-gen, virtual assistants. In contrast to a speech-to-text word matching algorithm, Clinc analyzes dozens of factors from the user’s input including wording, sentiment, intent, tone of voice, time of day, location, and relationships, and uses those factors to deliver an answer that represents a composite of knowledge extracted from its trained brain. Clinc's underlying technology is based on state-of-the-art machine learning and deep neural networks (DNN)-as-a-service developed by computer science professors at the University of Michigan. Clinc is a standalone “trained brain” that has been given an initial deep knowledge of the financial and banking industry. Its machine learning capabilities enable it to expand its knowledge with every query and to then draw from that knowledge for each subsequent customer query. The company was founded in 2015 and is based in Ann Arbor, Michigan.
Funding History
December 2015 | $250K |
---|---|
August 2016 | $1.2M |
February 2017 | $6.3M |
May 2019 | $52.0M |
Management
Founder & Managing Director
Andreas Sohns
Founder & CEO
Julien Arnold
Chief Product Officer and Co-Founder
Johann Hauswald
Chief Information Officer
Yunqi Zhang
Co-founder & CTO
Michael Laurenzano
Chief of Staff
Nicholas Orlando
COO
Lingjia Tang
Co-founder & CEO
Jason Mars
Press
Clinc expands to automotive, releases SaaS platform for its voice AI assistant
TechCrunch - Sep, 5 2018
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase